Buying Modis will add MT1621 to Zogenix’s pipeline, an investigational drug for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial DNA depletion disorder that affects children and ...

Thymidine Kinase 2 deficiency (TK2d) is a rare, life-threatening genetic disorder that primarily affects mitochondrial function due to mutations in the TK2 gene. This condition leads to a ...